The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $14.79

Today's change0.00 0.00%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $14.79

Today's change0.00 0.00%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

aTyr Pharma Inc closed at (U.S.)$14.79.

Over the last five days, shares have gained 5.34%, but are down 69.02% for the last year to date. Shares have underperformed the S&P 500 by 68.63% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $14.79
  • High--
  • Low--
  • Bid / Ask(U.S.) $10.14 / (U.S.) $29.27
  • YTD % change-69.02%
  • Volume0
  • Average volume (10-day)80,473
  • Average volume (1-month)70,925
  • Average volume (3-month)111,297
  • 52-week range(U.S.) $12.05 to (U.S.) $28.29
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.71
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue--0----
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense11966
Selling / general / administrative3222
Research & development8744
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----00
Other operating expenses, total--------
Operating income-11-9-6-6
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-11-9-6-7
Income after tax-11-9-6-7
Income tax, total--------
Net income-11-9-6-7
Total adjustments to net income0000
Net income before extra. items-11-9-6-7
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-11-9-6-7
Inc. avail. to common incl. extra. items-11-9-6-7
Diluted net income-11-9-6-7
Dilution adjustment--00--
Diluted weighted average shares15232323
Diluted EPS excluding extraordinary itemsvalue per share-0.74-0.40-0.27-0.30
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.74-0.40-0.28-0.29